BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11338665)

  • 1. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
    Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
    Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
    Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
    Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
    [No Abstract]   [Full Text] [Related]  

  • 7. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
    Chrzanowski K; Pałka J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
    Chrzanowski K; Bielawska A; Pałka J
    Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule based delivery systems for alkylating antineoplastic compounds.
    Bielawski K; Bielawska A
    ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
    Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
    J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis.
    Muszyńska A; Pałka J; Wołczyński S
    Pol J Pharmacol; 1998; 50(2):151-7. PubMed ID: 9798267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
    Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
    Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
    Mittal S; Song X; Vig BS; Amidon GL
    Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts.
    Miltyk W; Karna E; Pałka J
    Pol J Pharmacol; 1996; 48(6):609-13. PubMed ID: 9112701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue.
    Monks NR; Blakey DC; Curtin NJ; East SJ; Heuze A; Newell DR
    Br J Cancer; 2001 Sep; 85(5):764-71. PubMed ID: 11531265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study.
    Kryczka T; Kazimierczuk Z; Kozłowska M; Chrapusta SJ; Vilpo L; Vilpo J; Stachnik K; Janisz M; Grieb P
    Anticancer Drugs; 2007 Mar; 18(3):301-10. PubMed ID: 17264763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts.
    Karna E; Szoka L; Palka JA
    Pharmazie; 2010 Aug; 65(8):614-7. PubMed ID: 20824963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
    Wu Z; Shah A; Patel N; Yuan X
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
    Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
    Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.